Conditions: HMG-CoA Reductase Inhibitors-related Myalgias
Keywords: Vitamin D3 HMG-CoA reductase inhibitors (statin)-related myalgias
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 4
Healthy volunteers: no

Brief summary:
The purpose of this project is to determine if Vitamin D supplementation \[10,000 international units of cholecalciferol (vitamin D3) by mouth weekly\] will decrease the rate of discontinuation of statin therapy due to muscle ache/pain and decrease the occurrence of muscle ache/pain due to statin therapy.

Detailed description:

Arms:
arm 1: Subjects will receive Vitamin D supplementation 10,000 international units of cholecalciferol (vitamin D3) by mouth weekly arm 2: Subjects will receive placebo (an exact replica of the vitamin D capsule that does not contain any medically active substance) by mouth weekly

Interventions: intervention 1: cholecalciferol/placebo
Intervention descriptions: intervention 1: 10,000 IU by mouth weekly for 6 months

Protocol document: